Results 201 to 210 of about 2,302,312 (219)

Prevention and Early Detection Clinical Trials: Opportunities for Primary Care Providers and Their Patients

Ca-A Cancer Journal for Clinicians, 2003
Robert A Smith
exaly  

Biomarker enrichment strategies: matching trial design to biomarker credentials

Nature Reviews Clinical Oncology, 2013
Boris Freidlin
exaly  

Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension

Nature Medicine, 2020
Xiaoxuan Liu, An-Wen Chan, Alastair Denniston   +2 more
exaly  

American Cancer Society lung cancer screening guidelines

Ca-A Cancer Journal for Clinicians, 2013
Timothy R Church, Christopher R Flowers, Ya-Chen Tina Shih   +2 more
exaly  

MAIA under the microscope — bringing trial design into focus

Nature Reviews Clinical Oncology, 2019
Prashant Kapoor, S Vincent Rajkumar
exaly  

Issues with implementing a high‐quality lung cancer screening program

Ca-A Cancer Journal for Clinicians, 2014
James L Mulshine
exaly  

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

New England Journal of Medicine, 2020
Bin Cao, Ke Wang, Chaolin Huang
exaly  

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial

Lancet, The, 2008
Homer Yang, Gordon Guyatt, Kate Leslie
exaly  

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Lancet, The, 2016
Ian J Jacobs, Usha Menon, Andy Ryan
exaly  

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Lancet, The, 2012
Peter Sandercock, Joanna M Wardlaw, Richard I Lindley   +2 more
exaly